← Leaderboards
Joshua D Gross
West Virginia University
$289,434
Attributed
$289,434
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $69.8K · FY2017–22$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$289,434 · 2
By mechanism
F32$201,118 · 1
F31$88,316 · 1
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Cathrin M Buetefisch$5,266,344
Others in their field
Other Emerging Leaders on “Novel Therapeutics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Novel TherapeuticsTrainingGtp-Binding ProteinsNeuronsPharmaceutical PreparationsSocioeconomicsDopamine TransporterFutureMaintenanceMolecularNucleus AccumbensAddictionPublic HealthRewardsCocaineDopamineBiochemicalDrug Of AbuseCostKnockout MiceMediatingMesolimbic SystemAttenuatedVentral Tegmental Area
Grant awards (5)
Exploiting Biased Agonism at the Ghrelin Receptor (GHSR1a) for Opioid Addiction$69,802
F32 · FY2022 · DA · contact PI
Exploiting Biased Agonism at the Ghrelin Receptor (GHSR1a) for Opioid Addiction$66,390
F32 · FY2021 · DA · contact PI
Exploiting Biased Agonism at the Ghrelin Receptor (GHSR1a) for Opioid Addiction$64,926
F32 · FY2020 · DA · contact PI
The role of RGS12 in the action of amphetamine and related drugs of abuse$44,272
F31 · FY2018 · DA · contact PI
The role of RGS12 in the action of amphetamine and related drugs of abuse$44,044
F31 · FY2017 · DA · contact PI